Distinguishing COVID-19 from seasonal influenza in patients under age 65 years—a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1179552 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Wen Zhong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Fujian Shengli Medical College, Fujian Medical University, Fujian Provincial Hospital, Fuzhou, …. Hauptthemen laut MEDLINE: Influenza, Human, COVID-19, Influenza A Virus, H1N1 Subtype. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Major Science and Technology Projects of China, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Introduction
This study explored the differences in clinical characteristics between the 2009 pandemic influenza A (H1N1) and SARS-CoV-2 BA.2 variant (Omicron) infections in patients younger than age 65 years, to improve identification of these diseases and better respond to the current epidemic.
Methods
Data from 127 patients with the 2009 pandemic influenza A (H1N1) diagnosed between May and July of 2009 and 3,265 patients with Omicron diagnosed between March and May of 2022 were collected. Using a 1:2 match based on age (difference <2 years), sex, and underlying diseases, data from 115 patients with the 2009 pandemic influenza A (H1N1) infection (H1N1 group) and 230 patients with SARS-CoV-2 Omicron BA.2 infection (Omicron group) were analyzed. The clinical manifestations were compared between the groups, logistic regression was performed to identify possible independent risk factors for each group, and multiple linear regression was used to analyze the factors predicting time for nucleic acid negativization (NAN).
Results
The median [interquartile range] age of the two groups was 21 [11, 26] years. Compared with the H1N1 group, the Omicron group had: lower white blood cell counts and C-reactive protein levels; less fever, nasal congestion, sore throat, cough, sputum, and headache; and more olfactory loss, muscle soreness, and lactate dehydrogenase (LDH) abnormalities. Patients in the Omicron group used fewer antibiotics and antiviral drugs, and the time for NAN was longer (17 [14,20] VS 4 [3,5] days, P<0.001). Logistic regression showed that fever, cough, headache, and increased white blood cell count were more strongly correlated with the H1N1 group, while muscle soreness and LDH abnormalities were more strongly correlated with the Omicron group. Fever (B 1.529, 95% confidence interval [0.149,2.909], P=0.030) significantly predicted a longer time for NAN in patients with Omicron.
Discussion
There are significant differences in clinical characteristics between SARS-CoV-2 Omicron infection and the 2009 pandemic influenza A (H1N1) infection. Recognition of these differences has important implications for clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Fujian Shengli Medical College, Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China.
- Department of Hematology, Quanzhou First Hospital, Quanzhou, China.
- Department of Infectious Diseases, Quanzhou First Hospital, Fuzhou, China.
- The School of Nursing, Fujian Medical University, Fuzhou, China.
- Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
- Fujian Provincial Key Laboratory of Medical Big Data Engineering, Fujian Provincial Hospital, Fuzhou, China.
Förderung
- National Major Science and Technology Projects of China
- Natural Science Foundation of Fujian Province
Zitieren
APA
Zhong, W., Wu, Y., Yue, W., Fang, J., Xie, B., Xu, N., Lin, M., Zhu, X., Su, Z., Chen, Y., Li, H., & Li, H. (2023). Distinguishing COVID-19 from seasonal influenza in patients under age 65 years—a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1179552
Vancouver
Zhong W, Wu Y, Yue W, Fang J, Xie B, Xu N, et al. Distinguishing COVID-19 from seasonal influenza in patients under age 65 years—a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1179552
BibTeX
@article{Zhong2023,
author = {Zhong, Wen and Wu, Yisong and Yue, Wenxiang and Fang, Jiabin and Xie, Baosong and Xu, Nengluan and Lin, Ming and Zhu, Xiongpeng and Su, Zhijun and Chen, Yusheng and Li, Hong and Li, Hongru},
title = {Distinguishing COVID-19 from seasonal influenza in patients under age 65 years—a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1179552}
}
EUVIMED